Charles Schwab’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Charles Schwab’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-147,140	Closed	-$9.15M	–	3551
2023 Q4	$9.15M	Buy	+147,140	New	+$3.66M	﹤0.01%	2029

Charles Schwab's RYZB Position: Q1 2024 in Review

Charles Schwab sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 147,140 shares — an estimated $9.15M sold.

Charles Schwab first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $9.15M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Charles Schwab reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Charles Schwab sold 147,140 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $9.15M.
Charles Schwab first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Charles Schwab's RayzeBio, Inc. Common Stock position peaked at $9.15M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.